Iconovo AB (publ) (ICO.ST)
SEK 4.17
(-2.11%)
SEK 4.17
(-2.11%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | -4.86 Million SEK | -486200100.0% |
| 2022 | 1.00 SEK | 0.0% |
| 2021 | 1.00 SEK | -100.0% |
| 2020 | 467.07 Thousand SEK | 175.14% |
| 2019 | 169.75 Thousand SEK | 13.63% |
| 2018 | 149.4 Thousand SEK | 73.72% |
| 2017 | 86 Thousand SEK | 8599900.0% |
| 2016 | 1.00 SEK | 0.0% |
| 2015 | - SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | -7.41 Million SEK | 0.0% |
| 2024 Q1 | - SEK | 0.0% |
| 2024 Q2 | - SEK | -100.0% |
| 2023 FY | -4.86 Million SEK | -486200100.0% |
| 2023 Q3 | -6.1 Million SEK | 7.44% |
| 2023 Q2 | -6.59 Million SEK | -5.81% |
| 2023 Q4 | - SEK | 100.0% |
| 2023 Q1 | -6.23 Million SEK | -623500100.0% |
| 2022 Q2 | -5.8 Million SEK | -20.64% |
| 2022 Q4 | 1.00 SEK | 0.0% |
| 2022 FY | 1.00 SEK | 0.0% |
| 2022 Q1 | -4.81 Million SEK | -57.63% |
| 2022 Q3 | - SEK | 100.0% |
| 2021 Q1 | 478 Thousand SEK | 2.34% |
| 2021 FY | 1.00 SEK | -100.0% |
| 2021 Q4 | -3.05 Million SEK | 22.02% |
| 2021 Q3 | -3.91 Million SEK | -739.54% |
| 2021 Q2 | 612 Thousand SEK | 28.03% |
| 2020 Q4 | 467.07 Thousand SEK | 5.67% |
| 2020 FY | 467.07 Thousand SEK | 175.14% |
| 2020 Q1 | 277 Thousand SEK | 63.17% |
| 2020 Q2 | 501 Thousand SEK | 80.87% |
| 2020 Q3 | 442 Thousand SEK | -11.78% |
| 2019 Q1 | 181 Thousand SEK | 21.15% |
| 2019 Q4 | 169.75 Thousand SEK | -3.0% |
| 2019 Q3 | 175 Thousand SEK | 10.76% |
| 2019 FY | 169.75 Thousand SEK | 13.63% |
| 2019 Q2 | 158 Thousand SEK | -12.71% |
| 2018 Q3 | 74 Thousand SEK | 0.0% |
| 2018 FY | 149.4 Thousand SEK | 73.72% |
| 2018 Q1 | 86 Thousand SEK | 0.0% |
| 2018 Q2 | 74 Thousand SEK | -13.95% |
| 2018 Q4 | 149.4 Thousand SEK | 101.89% |
| 2017 FY | 86 Thousand SEK | 8599900.0% |
| 2017 Q4 | 86 Thousand SEK | 0.0% |
| 2017 Q1 | - SEK | 0.0% |
| 2016 FY | 1.00 SEK | 0.0% |
| 2015 FY | - SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | 171.092% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 104.012% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 104.012% |
| Arcoma AB | 28.02 Million SEK | 117.348% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 116.4% |
| BICO Group AB (publ) | 493.1 Million SEK | 100.986% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 107.792% |
| CellaVision AB (publ) | 126.03 Million SEK | 103.858% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | 179.509% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | 374.546% |
| C-Rad AB (publ) | 64.09 Million SEK | 107.585% |
| Duearity AB (publ) | 4.15 Million SEK | 216.903% |
| Dignitana AB (publ) | 7.41 Million SEK | 165.587% |
| Episurf Medical AB (publ) | 3.7 Million SEK | 231.405% |
| Getinge AB (publ) | 6.41 Billion SEK | 100.076% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | -188.825% |
| Integrum AB (publ) | 22.36 Million SEK | 121.742% |
| Luxbright AB (publ) | 8000.00 SEK | 60875.0% |
| Mentice AB (publ) | 14.1 Million SEK | 134.472% |
| OssDsign AB (publ) | 4.3 Million SEK | 212.965% |
| Paxman AB (publ) | 19.99 Million SEK | 124.311% |
| Promimic AB (publ) | 330 Thousand SEK | 1573.333% |
| Qlife Holding AB (publ) | 7.29 Million SEK | 166.676% |
| SciBase Holding AB (publ) | 11.91 Million SEK | 140.792% |
| ScandiDos AB (publ) | 22.69 Million SEK | 121.428% |
| Sectra AB (publ) | 36.59 Million SEK | 113.288% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 111.314% |
| Senzime AB (publ) | 20.34 Million SEK | 123.904% |
| SpectraCure AB (publ) | 1.00 SEK | 486200100.0% |
| Stille AB | 66.55 Million SEK | 107.305% |
| Vitrolife AB (publ) | 413 Million SEK | 101.177% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 103.434% |